Literature DB >> 2736830

Histological criteria of Sjögren's syndrome in scleroderma.

A Janin1, B Gosselin, D Gosset, P Y Hatron, B Sauvezie.   

Abstract

33 patients with scleroderma, xerostomia and xerophthalmia underwent biopsy of 3 to 5 labial salivary glands. Histological and ultrastructural study were systematically performed on the salivary gland specimen. In 27 patients, sclerosis was the main feature: it was an active fibrosis, with numerous secreting fibroblasts and degranulating mast cells. This fibrosis was located around capillaries and excretory ducts. It surrounded the acini, progressively destroying them. Lymphocytes were present but not very numerous. They were not grouped around the ducts but scattered in the fibrosis. 5 patients had similar fibrotic lesions but they also had numerous lymphocytes grouped in focus around excretory ducts as in primary Sjögren's syndrome. It is concluded that in scleroderma, xerostomia and xerophthalmia can be related either to a pure sclerotic process or to a 'common' secondary Sjögren's syndrome.

Entities:  

Mesh:

Year:  1989        PMID: 2736830

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  9 in total

1.  Mast cells, extracellular matrix components, TGFbeta isoforms and TGFbeta receptor expression in labial salivary glands in systemic sclerosis.

Authors:  G I Mason; J Hamburger; J B Matthews
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

2.  Bronchial hyperreactivity in systemic sclerosis patients: influence of associated Sjögren's syndrome.

Authors:  R La Corte; G Bajocchi; A Potena; M Govoni; F Trotta
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

3.  Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjögren's syndrome.

Authors:  M Hebbar; P Lassalle; Y Delneste; P Y Hatron; B Devulder; A B Tonnel; A Janin
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

4.  Orofacial manifestations of systemic sclerosis.

Authors:  B J Veale; R Y Jablonski; T M Frech; J D Pauling
Journal:  Br Dent J       Date:  2016-09-23       Impact factor: 1.626

Review 5.  Diagnosis and treatment of xerostomia (dry mouth).

Authors:  Joel J Napeñas; Michael T Brennan; Philip C Fox
Journal:  Odontology       Date:  2009-07-29       Impact factor: 2.634

6.  Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian Systemic Sclerosis Oral Health Study III.

Authors:  Murray Baron; Marie Hudson; Solène Tatibouet; Russell Steele; Ernest Lo; Sabrina Gravel; Geneviève Gyger; Tarek El Sayegh; Janet Pope; Audrey Fontaine; Ariel Masetto; Debora Matthews; Evelyn Sutton; Norman Thie; Niall Jones; Maria Copete; Dean Kolbinson; Janet Markland; Getulio Nogueira; David Robinson; Marvin Fritzler; Mervyn Gornitsky
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

Review 7.  Xerostomia due to systemic disease: a review of 20 conditions and mechanisms.

Authors:  H Mortazavi; M Baharvand; A Movahhedian; M Mohammadi; A Khodadoustan
Journal:  Ann Med Health Sci Res       Date:  2014-07

Review 8.  Prevalence of Oral and Maxillofacial Disorders in Patients with Systemic Scleroderma-A Systematic Review.

Authors:  Korbinian Benz; Christine Baulig; Stephanie Knippschild; Frank Peter Strietzel; Nicolas Hunzelmann; Jochen Jackowski
Journal:  Int J Environ Res Public Health       Date:  2021-05-14       Impact factor: 3.390

9.  Is IgG4-Related Disease a Cause of Xerostomia? A Cohort Study of 60 Patients.

Authors:  M Hermet; M André; J L Kémény; G Le Guenno; P Déchelotte; G Guettrot-Imbert; A Tridon; I Delèvaux; M Soubrier; O Aumaître
Journal:  Int J Rheumatol       Date:  2012-10-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.